ENO2 and neoplasm: As sudden and severe deterioration in condition, we called a rather short (1–2 months) phase of illness, in which the patients showed a remarkable enlargement of liver metastases and/or increase in number of tumor lesions along with an increase in transaminases and circulating tumor markers such as chromograninA and/or NSE.